New BIO report forecasts an uncertain future for the antibiotics sector
Lack of financial incentives for innovation or distinct pipelines have highlighted the need for reforms in the antibiotics sector.
View ArticleHow vaccine science could help tackle antimicrobial resistance
Successful vaccine technologies, such as mRNA and reverse vaccinology, could give researchers new approaches to fighting AMR.
View ArticleValneva receives up to £20m vaccine R&D funding in Scotland
The funding will be received in two separate grants, to support the manufacture of Valneva’s Covid-19 jab and other vaccines.
View ArticleProfit for patients: can NFTs allow people to monetise their health data?
Health data NFTs could democratise access to medical information, but challenges around the nascent technology must first be addressed.
View ArticleUkraine: Russian invasion could cause spike in Covid-19 cases
Experts fear Covid-19 cases in Ukraine, where only 35% of people are double-vaccinated, could spike as a result of Russia's invasion.
View ArticleNew bill seeks to revamp FDA’s accelerated approvals programme
The Accelerated Approval Integrity Act would help the US regulator ensure drugs granted speedy approval provide real benefits for patients.
View ArticleTwo years of Covid-19: lessons the pandemic taught about delivering essential...
From the value of collaboration to the need to plan ahead, pharma can learn from the pandemic when it comes to supplying other essential vaccines.
View ArticleUS Pharmacopeia report finds high reliance on Indian manufacturers for APIs
The USP's report on global API supply chain vulnerabilities indicates the outsized importance of and dependency on overseas manufacturers.
View ArticleBacteria and balance: how understanding the vaginal microbiome can help...
Imbalance in the vaginal microbiome has been linked to a range of conditions, from UTIs to preterm birth.
View Article